Hepanor70 mg

Hepanor is a standardized herbal extract used as a hepatoprotective (liver-supporting) agent. Evidence for its uses varies in strength:

• Traditional/complementary use (most common): Supportive treatment in chronic liver disorders such as alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD), chronic hepatitis (viral or drug/toxin-induced), and liver cirrhosis, generally as an adjunct alongside standard medical management, not as a replacement for it.
• Adjunct use: Supportive care for drug-induced or toxin-induced hepatotoxicity, and as an adjunct in fatty liver associated with diabetes/metabolic disease.
• Specific recognized use (outside typical oral supplement use): An intravenous form of a silymarin component (silibinin) is used in some countries as an antidote for Amanita phalloides (death cap mushroom) poisoning; this is a specialized hospital-based use distinct from routine oral supplementation.

Overall clinical trial evidence for definitive, disease-modifying benefit is limited and mixed; Hepanor should not delay or replace appropriate medical evaluation and treatment of underlying liver disease.

Hepanor is a standardized botanical extract obtained from the fruits (seeds) of the milk thistle plant (Silybum marianum). It is classified as a herbal/nutraceutical product and contains a mixture of flavonolignans collectively referred to as silymarin, of which silibinin is the most biologically active component.

Hepanor is widely used in traditional and complementary medicine to support liver function and is available in Bangladesh as an oral capsule/tablet formulation.

Hepanor belongs to the herbal and nutraceutical drug class, specifically categorized as a hepatoprotective (liver-protective) agent.

Silymarin [Dried extract of Milk Thistle fruits] exerts hepatoprotective effects through several proposed mechanisms:

• Antioxidant activity: Scavenges free radicals generated during hepatocyte toxin metabolism and increases intracellular antioxidant (e.g., glutathione) content; its antioxidant potency has been reported to exceed that of vitamin E.
• Membrane stabilization: Alters hepatocyte cell membrane structure, reducing penetration of hepatotoxins into cells.
• Protein synthesis stimulation: Stimulates RNA polymerase I activity, enhancing ribosomal protein synthesis and supporting hepatocyte regeneration and repair.
• Anti-inflammatory effects: Downregulates inflammatory pathways (e.g., NF-κB, COX-2), reducing pro-inflammatory cytokine production.
• Antifibrotic effects: Inhibits transformation of hepatic stellate cells into collagen-producing myofibroblasts, reducing fibrosis.

Despite these plausible mechanisms, clinical outcome data supporting definitive disease-modifying benefit from Silymarin [Dried extract of Milk Thistle fruits] remain limited and inconsistent across studies.

Clinically significant interactions with Hepanor are uncommon at typical doses, but the following should be noted:

• CYP450-metabolized drugs: Silymarin has mild inhibitory effects on some cytochrome P450 enzymes (e.g., CYP2C9, CYP3A4) and on drug transport/glucuronidation pathways. Clinical significance at usual doses is generally considered low, but caution is reasonable with narrow-therapeutic-index drugs (e.g., warfarin, some anticonvulsants).
• Antidiabetic medications: May have an additive blood-glucose-lowering effect; monitor for hypoglycemia when used with insulin or oral hypoglycemics.
• Antiplatelet/anticoagulant drugs: Theoretical additive effect on bleeding risk; use with caution.
• Butyrophenones/phenothiazines: Concomitant use has been reported to reduce lipid peroxidation effects associated with these agents.

These interactions should not delay or replace appropriate medical evaluation and treatment of underlying liver disease. Inform your physician of all medications and supplements being used alongside Hepanor.

Hepanor is generally well tolerated. Reported adverse effects are usually mild and include:

• Gastrointestinal upset, mild laxative effect, bloating, or diarrhea
• Headache
• Allergic/dermatological reactions such as rash, pruritus, or urticaria, particularly in individuals sensitive to Asteraceae/Compositae family plants (see Contraindications)

Serious adverse effects are rare at recommended doses. Discontinue and seek medical attention if signs of a significant allergic reaction (e.g., swelling, difficulty breathing) occur.

Data on the safety of Hepanor during pregnancy and lactation are limited. As a precaution, Hepanor should be used during pregnancy only if clearly needed and if the potential benefit justifies the potential risk to the fetus, and only under medical guidance. Similarly, use during breastfeeding should occur only under medical supervision, since robust safety data are lacking, even though available data have not shown significant transfer into breast milk. Consult a physician before use in pregnancy or lactation.

Hepanor is a supportive/adjunctive therapy and should not be used to delay or replace appropriate medical evaluation and treatment of underlying liver disease. Additional precautions:

• Use with caution in individuals with known allergies to Asteraceae/Compositae family plants (see Contraindications).
• Use with caution in patients on narrow-therapeutic-index medications, antidiabetic drugs, or antiplatelet/anticoagulant therapy (see Interactions).
• Patients with underlying liver disease should remain under regular medical follow-up (e.g., liver function monitoring) rather than relying on Hepanor alone.
• Product standardization can vary between manufacturers; use a reputable, quality-assured product as advised by a physician or pharmacist.

Reports of toxicity from Hepanor are rare, and it is generally considered to have a wide margin of safety at recommended doses. Very high doses have been associated with transient elevations in liver enzymes in isolated reports. In case of suspected overdose or accidental ingestion of a large amount, seek immediate medical attention or contact a poison control center rather than attempting home treatment.

Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children.

Pediatric use: Safety and efficacy of Hepanor in children have not been well established; use only under direct medical supervision.

Elderly: No specific dose adjustment is established for elderly patients; use as advised by a physician, considering concurrent medications and hepatic status.

Hepatic impairment: While used as a supportive agent in liver disease, patients with significant hepatic impairment should use Hepanor only under medical supervision, with appropriate monitoring.

Renal impairment: No well-established dose adjustment is required; use with general caution and physician guidance.

Herbal and Nutraceuticals; Hepatoprotective agents

Silymarin [Dried extract of Milk Thistle fruits] acts primarily through antioxidant, membrane-stabilizing, anti-inflammatory, and antifibrotic mechanisms in hepatocytes, along with stimulation of ribosomal protein synthesis that supports liver cell regeneration. See Pharmacology for details.

Use of Hepanor in children has not been well studied, and safety and efficacy in the pediatric population have not been firmly established. If considered necessary, use in children should only occur under the direct supervision and advice of a physician, with an individualized dose.